🟢 EIQ.AX is trading 31% up today on Pro Medicus funding and US distribution deal

EIQ.AX is trading 31% up at A$1.62 after securing a strategic A$20 million funding package and U.S. distribution partnership with Pro Medicus.

• Echo IQ entered a binding framework for up to A$20 million in secured convertible notes and debt to accelerate the commercialization of its EchoSolv cardiology AI platform.
• The agreement includes a U.S. reseller and distribution deal with Pro Medicus, a leading health imaging group, providing a significant pathway into the American healthcare market.
• The deal strengthens the company's balance sheet and provides major industry validation of its technology, driving strong investor interest.